Chronicle Journal: Finance

NIH halts trial of Covid plasma treatment after researchers found no benefit

The NIH halted a trial testing convalescent plasma in patients with mild-to-moderate Covid-19 symptoms after an independent group concluded it was unlikely to be beneficial.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.